NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Treatment of Tuberculosis in HIV-Infected Patients

Phase 3

Completed

Conditions: HIV Infections
Tuberculosis

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 650

Registration Number: NCT00001033

Locations: 🇺🇸
Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
🇺🇸
Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸
Cook County Hosp. CORE Ctr., Chicago, Illinois, United States

and more 9 locations

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

Not Applicable

Withdrawn

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2023-04-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00001070

A "Pre-Enrollment" Protocol for HIV-Infected Adolescents

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 250

Registration Number: NCT00000780

Locations: 🇺🇸
Children's Hosp of Boston, Boston, Massachusetts, United States
🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
UCLA Med Ctr / Pediatric, Los Angeles, California, United States

and more 48 locations

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 40

Registration Number: NCT00000984

Locations: 🇺🇸
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl, Newark, New Jersey, United States
🇺🇸
Duke Univ Med Ctr, Durham, North Carolina, United States
🇺🇸
Northern California Pediatric AIDS Treatment Ctr / UCSF, San Francisco, California, United States

and more 3 locations

A Phase I Randomized Dose/Formulation Comparison Study of SC-52151

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 48

Registration Number: NCT00000806

Locations: 🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States

and more 1 locations

A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1100

Registration Number: NCT00001069

Locations: 🇺🇸
Community Consortium of San Francisco, San Francisco, California, United States
🇺🇸
Veterans Administration Med Ctr / Regional AIDS Program, Washington, District of Columbia, United States
🇺🇸
The Research and Education Group, Portland, Oregon, United States

and more 14 locations

A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts

Completed

Conditions: Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 250

Registration Number: NCT00000908

Locations: 🇺🇸
Kaiser Permanente LAMC, Los Angeles, California, United States
🇺🇸
Marin County Specialty Clinic, San Rafael, California, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

and more 51 locations

A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 70

Registration Number: NCT00000840

Locations: 🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸
Ohio State Univ Hosp Clinic, Columbus, Ohio, United States

and more 5 locations

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

Phase 1

Completed

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 30

Registration Number: NCT00000642

Locations: 🇺🇸
Texas Children's Hosp / Baylor Univ, Houston, Texas, United States
🇺🇸
SUNY - Brooklyn, Brooklyn, New York, United States

A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 40

Registration Number: NCT00000775

Locations: 🇺🇸
St Louis Univ School of Medicine, St Louis, Missouri, United States
🇺🇸
Univ of Rochester Med Ctr, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy